Manchester scientists have a developed a new method to monitor the effect of anti-cancer drugs on very rare leukaemia stem cells. The approach potentially allows doctors to screen patients and personalise their treatment.
http://ift.tt/1DObYQt
http://ift.tt/1DObYQt
No comments:
Post a Comment